Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RODOLFO TREJO

Allopathic & Osteopathic Physicians Family Medicine

NPI
1750335584
CMS profile
215763
Location
ATLANTIS, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$6,132.23

197 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 4 of 4; records 151–197 of 197 matching records. This page contains 47 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RODOLFO TREJO

NPI 1750335584 · CMS profile ID 215763

Allopathic & Osteopathic Physicians / Family Medicine

ATLANTIS, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–197 of 197 matching records. This page contains 47 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1750335584?year=2024&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RODOLFO TREJO, NPI 1750335584, CMS profile ID 215763. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–197 of 197 matching records. This page contains 47 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1750335584?year=2024&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). RODOLFO TREJO, NPI 1750335584, CMS profile ID 215763. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–197 of 197 matching records. This page contains 47 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1750335584?year=2024&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
RODOLFO TREJO, NPI 1750335584, CMS profile ID 215763, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–197 of 197 matching records. This page contains 47 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1750335584?year=2024&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

197 matching records · $6,132.23 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 197 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–197 of 197.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.5203/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153486321 CMS
Teva Pharmaceuticals USA, Inc. $20.8103/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151614066 CMS
ABBVIE INC. $24.8903/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106242196 CMS
AstraZeneca Pharmaceuticals LP $125.0003/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110530931 CMS
Novo Nordisk Inc $9.0303/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096826604 CMS
Novo Nordisk Inc $14.5803/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096590291 CMS
Lundbeck LLC $17.3903/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145976287 CMS
Amgen Inc. $26.5103/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117703944 CMS
GlaxoSmithKline, LLC. $21.4403/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116000468 CMS
Abbott Laboratories $19.8503/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125238568 CMS
Esperion Therapeutics, Inc. $6.2203/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1129458096 CMS
Otsuka America Pharmaceutical, Inc. $29.6503/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118995400 CMS
AstraZeneca Pharmaceuticals LP $115.1103/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110549190 CMS
ABBVIE INC. $21.6703/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106242194 CMS
AstraZeneca Pharmaceuticals LP $13.4403/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110549296 CMS
PFIZER INC. $15.9703/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131213627 CMS
PFIZER INC. $23.4002/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131247030 CMS
Mylan Specialty L.P. $20.1402/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147335499 CMS
Phathom Pharmaceuticals, Inc. $126.4202/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151134157 CMS
AstraZeneca Pharmaceuticals LP $21.9702/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110538289 CMS
Lilly USA, LLC $21.0802/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135400753 CMS
MERZ NORTH AMERICA, INC. $36.7202/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146374566 CMS
ABBVIE INC. $16.5202/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106242192 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.8902/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137689092 CMS
AstraZeneca Pharmaceuticals LP $118.7502/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110545847 CMS
Otsuka America Pharmaceutical, Inc. $27.7502/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118995398 CMS
ABBVIE INC. $14.6002/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106242190 CMS
Teva Pharmaceuticals USA, Inc. $13.5202/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151614056 CMS
ABBVIE INC. $21.3602/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106242188 CMS
AstraZeneca Pharmaceuticals LP $17.2002/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110547430 CMS
Otsuka America Pharmaceutical, Inc. $29.7002/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118995396 CMS
ABBVIE INC. $123.9601/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106242186 CMS
AstraZeneca Pharmaceuticals LP $13.8101/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110545453 CMS
Exact Sciences Corporation $22.9701/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114934771 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.3801/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153678178 CMS
Novo Nordisk Inc $16.9501/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096653618 CMS
GlaxoSmithKline, LLC. $25.3401/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116259143 CMS
ABBVIE INC. $23.3301/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106242184 CMS
AstraZeneca Pharmaceuticals LP $21.3501/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110534856 CMS
AstraZeneca Pharmaceuticals LP $101.7601/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110540015 CMS
ABBVIE INC. $24.8901/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106242182 CMS
Otsuka America Pharmaceutical, Inc. $14.9801/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118995394 CMS
ABBVIE INC. $21.3501/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106242180 CMS
Mylan Specialty L.P. $23.3001/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147319770 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.3701/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153632546 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.7501/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086230904 CMS
Otsuka America Pharmaceutical, Inc. $28.4201/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118995392 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $6,704.32 229
PY2020 $4,515.28 207
PY2021 $6,506.66 276
PY2022 $4,406.78 192
PY2023 $5,192.77 200
PY2024 $6,132.23 197
PY2025 $6,408.18 195

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $904,092.33 64
PY2024 Principal investigator $2,803,407.63 46
PY2023 Principal investigator $4,120,045.45 42
PY2022 Principal investigator $260,204.47 71
PY2021 Principal investigator $190,244.96 59
PY2020 Principal investigator $49,858.53 8
PY2019 Principal investigator $55,214.33 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

64 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Ionis Pharmaceuticals, Inc. $900.00 10/31/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246789898
Principal investigator 1 AstraZeneca UK Limited $749.70 10/22/2025 Non-covered Recipient Entity
GENESIS TRUST RESEARCH
a twelfeweek randomized doubleblind phase four study evaluating the effect of airsupra compared to albuterol administered as needed on changes in airway inflammation symptoms and rescue therapy utilization in adults with mild asthma darwin No dispute reported 06/30/2026 1185551133
Principal investigator 1 Ionis Pharmaceuticals, Inc. $154,113.50 10/16/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246789299
Principal investigator 1 Ionis Pharmaceuticals, Inc. $1,200.00 10/14/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246788836
Principal investigator 1 Ionis Pharmaceuticals, Inc. $1,275.00 10/14/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246788840
Principal investigator 1 Ionis Pharmaceuticals, Inc. $1,500.00 10/14/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246788844
Principal investigator 1 Ionis Pharmaceuticals, Inc. $4,400.00 10/14/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246788848
Principal investigator 1 Ionis Pharmaceuticals, Inc. $64,145.64 10/14/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246788852
Principal investigator 1 Genentech, Inc. $2,798.00 09/10/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211566030
Principal investigator 1 Genentech, Inc. $6,315.00 08/27/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211566081
Principal investigator 1 Ionis Pharmaceuticals, Inc. $438.44 08/27/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246786866
Principal investigator 1 Ionis Pharmaceuticals, Inc. $855.45 08/06/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246786007
Principal investigator 1 Ionis Pharmaceuticals, Inc. $537.03 08/06/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246786276
Principal investigator 1 Genentech, Inc. $44,768.00 07/25/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211566086
Principal investigator 1 Ionis Pharmaceuticals, Inc. $895.05 07/18/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246785395
Principal investigator 1 Genentech, Inc. $2,798.00 07/16/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211566076
Principal investigator 1 Ionis Pharmaceuticals, Inc. $97.93 07/14/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246785272
Principal investigator 1 Ionis Pharmaceuticals, Inc. $640.00 07/14/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246785277
Principal investigator 1 Ionis Pharmaceuticals, Inc. $13,220.00 07/14/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246785281
Principal investigator 1 Genentech, Inc. $5,792.99 07/11/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211566018
Principal investigator 1 Genentech, Inc. $74,360.00 07/11/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211566038
Principal investigator 1 Genentech, Inc. $635.58 07/04/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211566069
Principal investigator 1 Genentech, Inc. $6,814.78 07/02/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211566022
Principal investigator 1 Genentech, Inc. $376.65 07/02/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211566050
Principal investigator 1 Genentech, Inc. $1,128.00 07/02/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211566094
Principal investigator 1 Ionis Pharmaceuticals, Inc. $895.05 06/25/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246784686
Principal investigator 1 Ionis Pharmaceuticals, Inc. $1,074.06 06/25/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246784690
Principal investigator 1 Ionis Pharmaceuticals, Inc. $1,074.06 06/25/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246784694
Principal investigator 1 Ionis Pharmaceuticals, Inc. $1,074.06 06/25/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246784697
Principal investigator 1 Ionis Pharmaceuticals, Inc. $716.04 06/25/2025 Non-covered Recipient Entity
3SYNC LLC
IS354CS9 No dispute reported 06/30/2026 1246784702
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $473.64 06/24/2025 Non-covered Recipient Entity
Genesis Trust Research
Phase III Safety and Efficacy of KarXT in Psychosis Associated with AD (ADEPT 4): 2 of 2 Acute Studies No dispute reported 06/30/2026 1235997169
Principal investigator 1 Genentech, Inc. $12,591.00 06/13/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565894
Principal investigator 1 Genentech, Inc. $3,380.00 06/13/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565907
Principal investigator 1 Genentech, Inc. $27.86 06/13/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565920
Principal investigator 1 Genentech, Inc. $414.30 06/13/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565988
Principal investigator 1 Genentech, Inc. $1,014.00 06/04/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565933
Principal investigator 1 Genentech, Inc. $48,965.00 05/30/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565874
Principal investigator 1 Genentech, Inc. $211,249.00 05/23/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565870
Principal investigator 1 Genentech, Inc. $338.00 05/21/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565959
Principal investigator 1 Genentech, Inc. $117.70 05/14/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565866
Principal investigator 1 Genentech, Inc. $58.85 05/14/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565891
Principal investigator 1 Genentech, Inc. $44.77 05/14/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565963
Principal investigator 1 Genentech, Inc. $2,632.51 04/25/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565955
Principal investigator 1 Genentech, Inc. $23,322.00 04/25/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211566002
Principal investigator 1 Genentech, Inc. $8,394.00 04/04/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565898
Principal investigator 1 Genentech, Inc. $3,042.00 03/21/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565779
Principal investigator 1 Genentech, Inc. $349.89 03/19/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565754
Principal investigator 1 Genentech, Inc. $376.20 03/19/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565839
Principal investigator 1 Genentech, Inc. $12,168.00 02/21/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565672
Principal investigator 1 Genentech, Inc. $4,453.33 02/21/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565692
Principal investigator 1 Genentech, Inc. $1,546.48 02/21/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565783
Principal investigator 1 Genentech, Inc. $237.75 02/21/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565795
Principal investigator 1 Genentech, Inc. $2,257.20 02/19/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565846
Principal investigator 1 Genentech, Inc. $5,596.00 02/14/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565792
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $25,729.00 02/12/2025 Non-covered Recipient Entity
Genesis Trust Research
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimers Disease (ADEPT-4) No dispute reported 06/30/2026 1235997167
Principal investigator 1 Genentech, Inc. $4,229.03 02/12/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565813
Principal investigator 1 Genentech, Inc. $419.01 02/07/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565729
Principal investigator 1 Genentech, Inc. $3,634.17 02/07/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565737
Principal investigator 1 Genentech, Inc. $8,394.00 02/05/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565663
Principal investigator 1 Genentech, Inc. $31,096.00 01/22/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565659
Principal investigator 1 AstraZeneca Pharmaceuticals LP $12,881.30 01/14/2025 Non-covered Recipient Entity
GENESIS TRUST RESEARCH
a twelfeweek randomized doubleblind phase four study evaluating the effect of airsupra compared to albuterol administered as needed on changes in airway inflammation symptoms and rescue therapy utilization in adults with mild asthma darwin No dispute reported 06/30/2026 1185551135
Principal investigator 1 Genentech, Inc. $7,723.33 01/14/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565710
Principal investigator 1 Genentech, Inc. $6,995.00 01/13/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565733
Principal investigator 1 Genentech, Inc. $64,354.00 01/13/2025 Non-covered Recipient Entity
3SYNC LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211565751